BioHealth News Archive

Venture Summit Virtual Connect

Venture Summit Virtual Connect

BioHealthInnovation invites you to join over 120 leading VCs, Corp VCs, Angel Investors and over 100Top Innovators online at Venture Summit Virtual Connect being…

Read More
Dr. Sally Mossman, Head of U.S. R&D for GSK Vaccines, Joins BioTalk to discuss their Rockville location, the BioHealth Capital Region, and the development of a COVID-19 Vaccine

Dr. Sally Mossman, Head of U.S. R&D for GSK Vaccines, Joins BioTalk to discuss their Rockville location, the BioHealth Capital Region, and the development of a COVID-19 Vaccine

Listen now via Apple https://apple.co/2RMiuoY, Google https://bit.ly/3iUXZCw, Spotify https://spoti.fi/32R5ll4, TuneIn https://bit.ly/33QE1m0, YouTube (Audio) https://bit.ly/367Ux47. Dr. Mossman obtained her Ph.D. in herpes virology from the University of Liverpool, UK. Thereafter…

Read More
1500 EAST GUDE DRIVE ROCKVILLE, MARYLAND – AVAILABLE NOW 21,400 RSF OF LABORATORY/OFFICE SPACE  (Alexandria)

1500 EAST GUDE DRIVE ROCKVILLE, MARYLAND – AVAILABLE NOW 21,400 RSF OF LABORATORY/OFFICE SPACE (Alexandria)

TENANT AMENITIES • Up to 21,400 RSF of office/lab suite available • Divisible to 9,529 RSF and 11,871 RSF • Conveniently located between Route…

Read More
5th Annual BioHealth Capital Region (BHCR) Crab Trap Competition (REGiSTER NOW!)

5th Annual BioHealth Capital Region (BHCR) Crab Trap Competition (REGiSTER NOW!)

Don't miss your chance to be named the BioHealth Startup with the Most Commercial Potential at the BHCR Forum, win $10,000 and more!  …

Read More
6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!)

6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!)

         

Read More
6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!)

6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!)

         

Read More
6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!) (2)

6th Annual BioHealth Capital Region Forum (Oct 19th, 2020) (REGISTER NOW!) (2)

         

Read More
EU pays $384 million for Sanofi-GSK COVID vaccine as WHO scheme deadline looms | Reuters

EU pays $384 million for Sanofi-GSK COVID vaccine as WHO scheme deadline looms | Reuters

BRUSSELS/PARIS (Reuters) - The European Union has agreed to buy a potential COVID-19 vaccine from Sanofi SASY.PA and GSK GSK.L in its second such…

Read More
Qiagen completes takeover of PCR automation player NeuMoDx for $248M | MedTech Dive

Qiagen completes takeover of PCR automation player NeuMoDx for $248M | MedTech Dive

Qiagen signed up to distribute the mid- and high-throughput versions of NeuMoDx’s PCR automation systems in major markets outside the U.S. in 2018. The…

Read More
Bio and Pharma Manufacturing Renaissance – YouTube

Bio and Pharma Manufacturing Renaissance – YouTube

Bio and Pharma Manufacturing Renaissance https://www.youtube.com/watch?v=PwqTWD7Ifcs&feature=youtu.be  

Read More
Roche receives U.S. emergency approval for coronavirus vs. flu test | Reuters

Roche receives U.S. emergency approval for coronavirus vs. flu test | Reuters

ZURICH (Reuters) - Drugmaker Roche on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug Administration for a test…

Read More
Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer (2)

Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer (2)

HOUSTON, Sept. 9, 2020 /PRNewswire/ -- Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood…

Read More
Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer

Kraton (BHI Client) Seeking Approval for BIAXAMTM as a Self-Sterilizing Sulfonated Polymer

HOUSTON, Sept. 9, 2020 /PRNewswire/ -- Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood…

Read More
Biotech-focused investor SR One is looking to raise $400m for its new fund | AltAssets Private Equity News

Biotech-focused investor SR One is looking to raise $400m for its new fund | AltAssets Private Equity News

SR One, a venture capital firm focused on the biotech space, is looking to raised up to $400m for its new fund. The firm…

Read More
Emergent Biosolutions pumps $75m into Canton facility – News – Canton Journal – Canton, MA

Emergent Biosolutions pumps $75m into Canton facility – News – Canton Journal – Canton, MA

Emergent BioSolutions will further strengthen its contract development and manufacturing capabilities by expanding into viral vector and gene therapy by investing $75 million in…

Read More